04/20/2025 05:51
Seven HKTDC Mega Events Showcase Asia’s Creative Hub

The Hong Kong Trade Development Council (HKTDC) is hosting seven mega events, including Hong Kong Gifts & Premium Fair, Home InStyle and Fashion InStyle (27-30 April at the Hong Kong Convention and Exhibition Centre, HKCEC); the Hong Kong International Printing & Packaging Fair and DeLuxe PrintPack Hong Kong (held concurrently at AsiaWorld-Expo); and the Hong Kong International Licensing Show and Asian Licensing Conference (28-30 April at the HKCEC). The events are set to draw some 6,00...

04/25/2025 12:00
Incyte to Highlight Early-Stage Oncology Data at American Association for Cancer Research Annual Meeting 2025

Incyte (Nasdaq:INCY) today announced that the Company will present new early-stage data from its oncology portfolio at the American Association of Cancer Research (AACR) Annual Meeting 2025 in Chicago, IL, from April 25–30. “At AACR we will be presenting data from early-stage programs across our oncology portfolio, including for patients with myeloproliferative neoplasms, ovarian cancer and other solid tumors,” said Pablo J. Cagnoni, M.D., President and Head of Research and Development, Incyte...

04/29/2025 09:45
Cubic³ Research Finds Automotive OEMs View Connectivity as Crucial for Security as Half of Consumers Worry Their Car Can Be Hacked

Research from Cubic³, a global leader in software-defined vehicle (SDV) solutions, emphasises the opportunities and challenges facing automotive OEMs as they persuade drivers to buy and subscribe to in-vehicle digital services, such as predictive maintenance, safety features and autonomous driving. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250429601913/en/ Boston Consulting Group forecasts the software-defined vehicle (SDV) mark...

05/08/2025 05:03
AB InBev Reports First Quarter 2025 Results

Anheuser-Busch InBev (Brussel:ABI) (BMV:ANB) (JSE:ANH) (NYSE:BUD): This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250507671244/en/AB InBev Strategic Priorities Regulated information1 “Beer is a passion point for consumers. The strength of the beer category and the continued momentum of our megabrands delivered another quarter of profitable growth. EBITDA increased at the top-end of our outlook and the ongoing optimization of our bus...

05/12/2025 16:30
Introducing Joblio – The Future of Ethical Recruitment

Joblio, a global ethical recruitment platform, officially launches today to tackle the broken labor migration system—long plagued by exploitative intermediaries, high recruitment fees, and human rights abuses. With its tech-driven model, Joblio connects vetted workers with employers directly, eliminating unethical middlemen and ensuring cost-free hiring for migrant workers. Employers fund access to talent, but workers never pay—a key step in ending exploitation. This press release features mult...

05/12/2025 17:04
Presidio Investors is Pleased to Announce the Addition of Christian Schütte as Its Newest Operating Partner

Christian brings more than 20 years of global experience in investment banking, private equity, and operational leadership, with a proven track record of driving transformational growth across industries. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250512473756/en/Christian Schütte Christian began his career at J.P. Morgan in New York and London, where he worked in the M&A and Corporate Finance teams. He later joined Fortress ...

04/29/2025 10:30
Compass Pathways Establishes Strategic Collaboration with HealthPort to Inform the Potential Delivery of COMP360 Synthesized Psilocybin Treatment in Underserved Communities

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation announced today it is entering into a strategic collaboration with HealthPort, a multi-site comprehensive community health organization. HealthPort employs an integrated model centered around social determinants of health and this collaboration will help inform the potential delivery of COMP360 synthesized psilocybin treatment in underserved communities, if FDA appr...

05/08/2025 06:36
Takeda Announces FY2024 Full Year Results and FY2025 Outlook Reflecting Growth & Launch Products Momentum, Strong Cash Flow Generation and Late-Stage Pipeline Progress

Takeda (TOKYO:4502/NYSE:TAK) today announced financial results for fiscal year 2024 (period ended March 31, 2025) with continued strong momentum in Growth & Launch Products offsetting loss of exclusivity impact to drive revenue and Core Operating Profit growth, supported by robust cost management. Takeda has built a high-value late-stage pipeline with potentially life-transforming new treatment options for patients. Following a positive Phase 3 readout for rusfertide in Oncology in March 2...